HPV Specimen Self-Collection for Cervical Cancer Screening Introduced by Quest
Quest Diagnostics has introduced a self-collection option for HPV screening, improving access to cervical cancer prevention.
Category: Cervical (HPV)
Cervical (HPV)
Latest
Cervical (HPV)
Latest
HPV Self-Collection Study Seeks to Improve Cervical Cancer Screening Access
A first-of-its-kind HPV self-collection pilot program has launched in Texas to improve cervical cancer screening access in underserved areas.
Cervical (HPV)
Latest
Noninvasive Urine Test Could be Key in Cervical Cancer Detection
Researchers developed a urine test using ELISA to detect HPV16 E7 oncoproteins, a noninvasive method for cervical cancer screening.
Rural-Urban Disparities in Cervical Cancer Screening
The research highlighted factors influencing cervical cancer screening and highlighted the need for interventions to increase screening.
Read More
CMS Designates HPV Blood Test as an Advanced Diagnostic Lab Test
The TTMV-HPV DNA blood test provides a non-invasive method for detecting HPV-driven cancers before there is clinical evidence of disease.
Read More
ASCCP Cervical Cancer Management Guidelines Support Dual-Stain Triage Testing
The ASCCP recognized dual-stain biomarkers as an important tech to determine if an HPV infection is transforming into cervical pre-cancer.
Read More
New Initiative Aims to Advance HPV-Driven Cancer Test
Naveris Launched an initiative aimed to expand the applications of its circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test.
Read More
BD and Camtech Health Partner to Improve Cervical Cancer Screening Access in Singapore
BD partnered with Camtech Health to advance cervical cancer screening by offering women in Singapore the option to self-collect a sample.
Read More
Cervical Cancer Screening: Survey Points to Self-Collection as Improving Access
In BD’s newest global survey, women reported self-collection would motivate them to have regular cervical cancer screening.
Read More
How Liquid Biopsy of Lymph Fluid Could Guide Head and Neck Cancer Treatment
Researchers discovered that lymphatic fluid from surgical drains could inform precise treatments for patients with head and neck cancer.
Read More
Roche Expands HPV Testing for Cobas 5800 Molecular System
Roche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.
Read More
FDA Approves Abbott HPV Test for Molecular PCR Platform
Abbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read More
Physically Disabled Women Less Likely to be Screened for Cervical Cancer
Physically disabled women may encounter barriers to reproductive health care and a lack of timely access to cervical cancer screening.
Read More
Liquid Biopsies can Rapidly Detect Residual Disease After Cervical Chemoradiation
Two liquid biopsy tests that look for HPV in blood identified patients with a high risk of cervical cancer recurrence after chemoradiation.
Read More
Researchers Develop Novel DNA Biosensor for Early Cervical Cancer Diagnosis
Researchers developed an electrochemical DNA biosensor which effectively detects HPV-16 and HPV-18, and can diagnose cervical cancer early.
Read More
New Test Detects Hard-to-Find Cervical Cancers
Scientists at the Montefiore Einstein Cancer Center developed a test for detecting a type of cervical cancer that Pap tests often miss.
Read More
New Ways to Track HPV-Positive Head, Neck Cancer Recurrence
New tests offer clinical and technological perspectives on how to measure if recurrence is happening earlier than current blood tests allow.
Read More
How to Close the Gaps in Cervical Cancer Screening
Self-collection could be an effective way to increase access to screening for cervical cancer, diagnosing the disease earlier.
Read More